أثر مصاريف البحث والتطوير عمى الاداء المالي لشركات الادوية المدرجة في بورصة عمان للاوراق المالية )دراسة اختباري( “The Impact of Research and Development Expenses on Financial Performance of Pharmaceutical Industrial Companies Listed at Amman Stock Exchange (ASE)” (Empirical Study)

نيروخ, منزر صالح (2017) أثر مصاريف البحث والتطوير عمى الاداء المالي لشركات الادوية المدرجة في بورصة عمان للاوراق المالية )دراسة اختباري( “The Impact of Research and Development Expenses on Financial Performance of Pharmaceutical Industrial Companies Listed at Amman Stock Exchange (ASE)” (Empirical Study). Masters thesis, جامعة الشرق الاوسط.

Text 5ae973e80fea9_1.pdf Download (2MB)

Abstract

This study aimed to demonstrate the impact of research and development expenses on financial performance of pharmaceutical industrial companies listed in Amman Stock Exchange. The study sample consisted of (7) pharmaceutical industrial companies for the period between 2007-2016. To achieve the study objectives, the researcher used the qualitative methodology based on an empirical study, to analyse the study data, the researcher used many statistical descriptive methods, such as means, standard deviation, and used simple regression and multiple regression analysis in testing the hypotheses of the study, based on statistical analysis software (SPSS). After processing and analyzing the study data and testing its hypotheses, the study revealed a number of results, includingthat there is no significant impact of research and development expenses on financial performance measured by both return on equity (ROE) and earning power (ROA), in pharmaceutical industrial companies listed in Amman Stock Exchange. The study also indicated that there is no significant impact of the firm size as a control variable on the explanatory ف power of research and development expenses on return on equity model, and a significant impact of the firm size as a control variable on the explanatory power of research and development expenses on earning power model, however it did not improve the impact of research and development expenses on earning power to remain insignificant. The main recommendations of the study were that Jordanian pharmaceutical companies should disclose the value of research and development expensesas a separate item in their financial statements, and should pay more attention to develop the laws and legislationwhich deal with the research and development expenses. Keywords: Research and Development Expenses, Financial Performance, Pharmaceutical Companies.

Actions (login required)

View Item